Palo Alto, CANCT06553768Now EnrollingIRB Ready

Cholestatic Liver Disease Clinical Trial in Palo Alto, CA

Access cutting-edge cholestatic liver disease treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Sponsored by Mirum Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Palo Alto location

Preparing your pre-screening questions...

Expert Care in Palo Alto

Access cholestatic liver disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cholestatic liver disease treatment provided free

Apply for This Palo Alto Location

Check if you qualify for this cholestatic liver disease clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Palo Alto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Palo Alto site if eligible
  4. 4Begin participation

About This Cholestatic Liver Disease Study in Palo Alto

The purpose of this study is to determine whether the investigational treatment (maralixibat) is safe and effective in pediatric and adult participants who have cholestatic liver disease with pruritus that has been refractory to other therapies, and who have no other treatment options.

Sponsor: Mirum Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Informed consent and assent (as applicable) 2. Age ≥6 months at time of baseline visit 3. Diagnosis of cholestatic liver disease with cholestatic pruritus based on the presence of chronic liver biochemical abnormalities (\>90 days) and/or pathological evidence of progressive liver disease. 4. If taking antipruritics or ursodeoxycholic acid, the participant has to be on a stable dosing regimen (i.e., same dose and frequency in the 30 days prior to the screening visit and will continue this dosing regimen up to Week 40 \[adjustment for body weight is allowed\]). 5. Access to email or telephone for scheduled participant contacts and access to smart phone or tablet for PROs. 6. Ability to read and/or understand the questionnaires (both caregivers and participants ≥9 years of age). 7. For participants ≤18 years of age: Access to consistent caregiver(s) during the study.

Exclusion Criteria

Those who meet any of the following criteria are NOT eligible to participate

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Palo Alto?

Yes, this clinical trial (NCT06553768) has an active research site in Palo Alto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cholestatic Liver Disease Treatment Options in Palo Alto, CA

If you're searching for cholestatic liver disease treatment options in Palo Alto, CA, this clinical trial (NCT06553768) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cholestatic liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cholestatic liver disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Palo Alto, CA

See all ankylosing spondylitis clinical trials recruiting in Palo Alto — not just this study.

Browse Ankylosing Spondylitis Trials in Palo Alto →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsLiver Disease TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Palo Alto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Palo Alto, CA